Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

ADVISORY -- Press Conference - 04/05/2007

ADVISORY -- Press Conference

Senator Barbara A. Mikulski press conference
Release Date: April 5, 2007

ADVISORY - PRESS CONFERENCE

WHAT: Senator Barbara A. Mikulski will visit Johns Hopkins to discuss stem cell research and the Stem Cell Research Enhancement Act of 2007.

WHO:
Senator Barbara A. Mikulski

Ronald R. Peterson, President of The Johns Hopkins Hospital and Health System, Executive Vice President of Johns Hopkins Medicine

Chi Van Dang, M.D., Ph,D., Professor of Medicine, Cell Biology, Oncology and Pathology, the Johns Hopkins Family Professor in Oncology Research, and Vice Dean for Research

Several JHM stem cell experts (partial list below)

WHEN: 11:30 a.m., Tuesday, April 10, 2007

WHERE:
The Weinberg Building Auditorium
401 North Broadway, Baltimore, MD 21231
http://www.hopkinskimmelcancercenter.org/about/weinbergdirections.cfm

Senator Barbara A. Mikulski will visit Johns Hopkins next week to talk firsthand with stem cell researchers and hold a press conference on the Stem Cell Research Enhancement Act of 2007 (S.5), which the Senate will begin debating next week. Several Hopkins stem cell experts will be on hand to answer questions (see partial list of attendees below).

The Stem Cell Research Enhancement Act would expand federally funded stem cell research and give scientists access to stem cell lines that are currently off-limits to federal funding, and establish a national framework of medical and bioethical guidelines. The bill would allow creation of new human embryonic stem cell lines derived from leftover embryos created by in vitro fertilization.

The Institute for Cell Engineering was launched at The Johns Hopkins University School of Medicine in January 2001. ICE supports and houses scientists working to understand how cells' fates are determined and to harness that information to select, modify and reprogram human cells. While basic research is the hallmark of ICE science, the ultimate goal is to mold engineered human cells into therapeutic transplants for a wide range of currently devastating diseases, including Parkinson's disease, Lou Gehrig's disease or amyotrophic lateral sclerosis (ALS), diabetes and heart failure.

Partial list of stem cell experts on hand to answer questions:

Curt Civin, M.D.
Professor, Oncology and Pediatrics
Herman and Walter Samuelson Professor in Oncology, Kimmel Cancer Center

Valina Dawson, Ph.D.
Professor, Neurology, Neuroscience and Physiology
Co-Director, ICE Neuroregeneration Program

John D. Gearhart, Ph.D.
Professor of Gynecology and Obstetrics, Physiology, Comparative Medicine, and Population Dynamics
Director, ICE Stem Cell Biology Program

Douglas Kerr, M.D., Ph.D.
Associate Professor of Neurology, Molecular Microbiology and Immunology
Director of the Johns Hopkins Transverse Myelitis Center

Jeffrey Rothstein, M.D., Ph.D.
Professor of Neurology
Director of the Robert Packard Center for ALS Research

For the Media

Media Contacts:

Audrey Huang; 410-614-5105; audrey@jhmi.edu
Nick Zagorski; 443-287-2251; nzagors1@jhmi.edu

 
 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer